Michael Wang,Life Sciences BU Manager Separation and Purification Sciences Division, 3M China 

Topic: Strategies to Mitigate the Cell Lysis during Cell Clarification Step Using Depth Filtration System 

Speaker Bio 

Joining 3M China in June 2018, Dr. Michael Wang brought with him over 20 years of experience working in the biotech and the bioprocessing industries. His current role is to serve as 3M SPSD division’s Life Sciences Business Unit Leader responsible for the entire Great China Region. Dr. Wang joined 3M US in 2006 as the Bioprocessing Marketing Manager. He was responsible for launching many commercially successful products that have brought millions in US$ of profits to 3M over the last decade. Prior to 3M, Dr. Wang held managerial positions at Protein Sciences Corporation (now part of Sanofi Pasteur) and was instrumental in developing the production process for FluBlok®, an FDA approved cell culture - based influenza vaccine. Dr. Wang holds a Ph.D in Biochemistry and Molecular Biology from Rutgers University and an MBA from Cornell University. 

Presentation Summary

 Currently in monoclonal antibody biologic drug manufacturing customers use reusable chromatography column to purify residual process and product impurities, virus clearance. The current solution is limited by load capacity, process efficiency/yield and product purity. 3M™ Polisher ST will replace the current solution with a single use solution with >100X loading capacity and >97% purity and better efficiencies enabling customers to modify their processes and make flexible and adaptable to new industry trends like process intensification and continuous manufacturing. The aim of this presentation is to introduce this exciting new product which is scheduled to be launched in the Greater China Area (GCA) in Q3 2020.